Availability of medicines in town and in the hospital

Availability of medicines in town and in the hospital


Many tensions.

Many tensions.GemaIbarra / iStock / Getty Images Plus / via Getty Images

Entre the 31 January and February 4, 2025, the National Agency for the Safety of Medicines and Health Products (ANSM) reported new disturbances or updated the availability data of several specialties marketed in France [1] Distributed on the double canal city/hospital.

Bi Tildiem LP: the dosage at 90 mg under tension

BI TILDIEM LP 90 mg Polished release coated tablet (Diltiazem chlorhydrate)

Availability statement according to the ANSM

  • Situation one would: tension
  • Situation in the hospital: not impacted
  • Quantitative quota in town
  • Date of discount scheduled: during May 2025

Calcidia: Discount made available in June 2025

Calcidia 1.54 g pellet for oral suspension in bagpipes (calcium carbonate)

Availability statement according to the ANSM

Lytos: supply under tension until spring 2025

Lytos 520 mg film -coated tablet (Anhydrous sodium clodronate)

Availability statement according to the ANSM

  • Situation one would: tension
  • Hospital situation: tension
  • Quantitative quota in town and hospital
  • Date of discount scheduled: end of March 2025

Additional information by the laboratory

Quétiapine LP specialties: general supply tension

Specialties of quetiapine LP (XEROQUEL LP) 50 mg, 300 mg and 400 mg tablet for prolonged release : all laboratories

Availability statement according to the ANSM

  • Supply voltage general
  • Establishment of quantitative quota for the city circuit, hospitals and overseas departments and regions (DROM) are not impacted by this contingation
  • Undetermined presentation

Additional information

Conducive to hold in the context of supply tensions (cf. Our full article of 4 February 2025)

Related Articles